Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
暂无分享,去创建一个
N. Rougier | E. Bézard | J. Obeso | M. Herrero | M. Vila | B. Mollenhauer | M. Goillandeau | T. Leste-Lasserre | M. Bourdenx | Aurélien Nioche | S. Dovero | Marie-Laure Arotcarena | S. Camus | G. Porras | Marie-Laure Thiolat | A. Prigent | P. Aubert | S. Bohic | C. Sandt | F. Laferrière | E. Doudnikoff | N. Kruse | S. Novello | M. Morari | I. Damas | C. Perier | C. Estrada | N. García-Carrillo | A. Recasens | N. Vaikath | O. El‐Agnaf | P. Derkinderen | B. Dehay | I. T. Damas | Marie-Laure Arotçarena
[1] Elisabet Englund,et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.
[2] Davide Castelvecchi,et al. Can we open the black box of AI? , 2016, Nature.
[3] C. Dobson,et al. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice , 2019, The Journal of Biological Chemistry.
[4] Qin Li,et al. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression , 2015, Acta neuropathologica communications.
[5] J. Trojanowski,et al. Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.
[6] P. Hof,et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease , 2003, Acta Neuropathologica.
[7] C D Marsden,et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.
[8] M. Giugliano,et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.
[9] Qin Li,et al. Lentiviral Overexpression of GRK6 Alleviates l-Dopa–Induced Dyskinesia in Experimental Parkinson’s Disease , 2010, Science Translational Medicine.
[10] D. Krainc,et al. α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies , 2017, Nature Medicine.
[11] Juan José Rodríguez Diez,et al. On feature selection protocols for very low-sample-size data , 2018, Pattern Recognit..
[12] M. Vila,et al. Pathogenic Lysosomal Depletion in Parkinson's Disease , 2010, The Journal of Neuroscience.
[13] R. Riek,et al. Cryo-EM structure of alpha-synuclein fibrils , 2018, bioRxiv.
[14] D. James Surmeier,et al. Selective neuronal vulnerability in Parkinson disease , 2017, Nature Reviews Neuroscience.
[15] Nicholas K. Sauter,et al. Structure of the toxic core of α-synuclein from invisible crystals , 2015, Nature.
[16] Federico N. Soria,et al. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration , 2017, Human molecular genetics.
[17] E. Bézard,et al. Rise and fall of minocycline in neuroprotection: need to promote publication of negative results , 2004, Experimental Neurology.
[18] B. Mollenhauer,et al. Novel One-step Immunoassays to Quantify α-Synuclein , 2012, The Journal of Biological Chemistry.
[19] Xueming Li,et al. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy , 2018, Cell Research.
[20] N. Rougier,et al. Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in non-human primates , 2019, bioRxiv.
[21] D. Eisenberg,et al. Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs , 2019, Nature Structural & Molecular Biology.
[22] H. Kretzschmar,et al. Regional Distribution of Proteinase K‐Resistant α‐Synuclein Correlates with Lewy Body Disease Stage , 2004, Journal of neuropathology and experimental neurology.
[23] R. Hauser,et al. Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.
[24] Charles D. Schwieters,et al. Solid-State NMR Structure of a Pathogenic Fibril of Full-Length Human α-Synuclein , 2016, Nature Structural &Molecular Biology.
[25] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[26] E. Bézard,et al. Birth Origin Differentially Affects Depressive-Like Behaviours: Are Captive-Born Cynomolgus Monkeys More Vulnerable to Depression than Their Wild-Born Counterparts? , 2013, PloS one.
[27] J. Koh,et al. Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment , 2009, Brain Research.
[28] J. Bolam,et al. Living on the edge with too many mouths to feed: Why dopamine neurons die , 2012, Movement disorders : official journal of the Movement Disorder Society.
[29] J. Trojanowski,et al. Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes. , 2019, Brain : a journal of neurology.
[30] J. Altmann,et al. Observational study of behavior: sampling methods. , 1974, Behaviour.
[31] E. Bézard,et al. Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys , 2014, Annals of neurology.
[32] E. Bézard,et al. Depressive-like behavioral profiles in captive-bred single- and socially-housed rhesus and cynomolgus macaques: a species comparison , 2014, Front. Behav. Neurosci..
[33] R. Taschereau,et al. Rank–rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures , 2010, Nucleic acids research.
[34] D. Mann,et al. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology , 2015, Neurobiology of Disease.
[35] A. Petrie,et al. Regional differences in the severity of Lewy body pathology across the olfactory cortex , 2009, Neuroscience Letters.
[36] G. Halliday,et al. Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts , 2019, Nature Communications.
[37] Michael Johnson,et al. Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis , 2019, Trends in Neurosciences.
[38] M. Fändrich,et al. FTIR reveals structural differences between native β‐sheet proteins and amyloid fibrils , 2004, Protein science : a publication of the Protein Society.
[39] E. Hirsch,et al. Neuroinflammation in Parkinson's disease. , 2012, Parkinsonism & related disorders.
[40] Alain Dagher,et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years , 2008, Nature Medicine.
[41] Mingyan Liu,et al. Decreased circulating Zinc levels in Parkinson’s disease: a meta-analysis study , 2017, Scientific Reports.
[42] E. Bézard,et al. Alpha‐synuclein propagation: New insights from animal models , 2016, Movement disorders : official journal of the Movement Disorder Society.
[43] Gregory Piatetsky-Shapiro,et al. Knowledge Discovery in Databases: An Overview , 1992, AI Mag..
[44] P. Hantraye,et al. Translational research for Parkinson׳s disease: The value of pre-clinical primate models. , 2015, European journal of pharmacology.
[45] A. Ballabio,et al. Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis , 2019, Nature Communications.
[46] B Bioulac,et al. Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease , 2001, The Journal of Neuroscience.
[47] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[48] Fred H. Gage,et al. In vivo demonstration that α-synuclein oligomers are toxic , 2011, Proceedings of the National Academy of Sciences.
[49] E. Bézard,et al. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies , 2017, Progress in Neurobiology.
[50] Joel Nothman,et al. Author Correction: SciPy 1.0: fundamental algorithms for scientific computing in Python , 2020, Nature Methods.
[51] A. Cuervo,et al. Proteostasis and aging , 2015, Nature Network Boston.
[52] Raphaella W. L. So,et al. α-Synuclein strains target distinct brain regions and cell types , 2019, Nature Neuroscience.
[53] A. Mackay-Sim,et al. Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction , 2014, Human molecular genetics.
[54] Sebastian Thrun,et al. Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.
[55] E. Bézard,et al. Behavioural Profiles in Captive-Bred Cynomolgus Macaques: Towards Monkey Models of Mental Disorders? , 2013, PloS one.
[56] Joel Nothman,et al. SciPy 1.0-Fundamental Algorithms for Scientific Computing in Python , 2019, ArXiv.
[57] Kurt Hornik,et al. Multilayer feedforward networks are universal approximators , 1989, Neural Networks.
[58] R. Wade-Martins,et al. Alpha-synuclein oligomers: a new hope , 2017, Acta Neuropathologica.
[59] V. Beneš,et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.
[60] B. Meier,et al. Structural and functional characterization of two alpha-synuclein strains , 2013, Nature Communications.